colon and rectal (colorectal) cancer Archive — Page 3 of 13
-
November 7, 2022
Marathon Mission
-
September 13, 2022
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib. -
August 17, 2022
Trial for colorectal cancer drug reaches primary endpoint
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial. -
July 28, 2022
C. difficile may contribute to colorectal cancer: study
A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer. -
July 21, 2022
Researchers find potential new target against colorectal cancer
-
July 12, 2022
Probing the tumor microenvironment
Vanderbilt researchers used single-cell sequencing, imaging, and computational approaches to characterize the colonic tumor microenvironment, providing important insights to the components that play roles in colorectal tumor pathogenesis. -
June 2, 2022
Choi, Short receive AGA Research Foundation Awards
Two Vanderbilt researchers have received awards from the AGA Foundation, the charitable arm of the American Gastroenterological Association.